 | 1939 - 1522 lapas
...the act if it complies with all of the following conditions: (1) Such drug or device, because of its toxicity or other potentiality for harmful effect...use or the collateral measures necessary to its use, is not generally recognized among experts qualified by scientific training and experience to evaluate... | |
 | United States. Food and Drug Administration - 1959 - 1068 lapas
...proscribes the dispensing of a drug without the prescription of a physician, when because of its toxicity or other potentiality for harmful effect,...use, or the collateral measures necessary to its use, is not safe for use except under the supervision of a practitioner licensed bj law to administer such... | |
 | United States - 1977 - 1276 lapas
...which (A) is a habit-forming drug to which section 352(d) of this title applies; or (B) because of its toxicity or other potentiality for harmful effect,...use, or the collateral measures necessary to its use, is not safe for use except under the supervision of a practitioner licensed by law to administer such... | |
 | 1981 - 1252 lapas
...prescription-dispensing requirements when the Commissioner finds such requirements are not necessary for the protection of the public health by reason...the prescription-dispensing requirements of section 503(b)(l)(C) of the act may be initiated by the Commissioner or by any interested person. Any interested... | |
 | 1996 - 1128 lapas
...prescriptiondispensing requirements when the Commissioner finds such requirements are not necessary for the protection of the public health by reason...in proposed labeling. A proposal to exempt a drug 1 from the prescription-dispensing requirements of section 503(b)(l)(C) of the act may be initiated... | |
 | 1998 - 1162 lapas
...not necessary for the protection of the public health by reason of the 12 §310.201 drug's toxiclty or other potentiality for harmful effect, or the method...the prescription-dispensing requirements of section 503(b)(l)(C) of the act may be initiated by the Commissioner or by any interested person. Any interested... | |
 | 1965 - 1520 lapas
...prescription-dispensing requirements when the Commissioner finds such requirements are not necessary for the protection of the public health by reason...finds that the drug is safe and effective for use in self -medication as directed in proposed labeling. A proposal to exempt a drug from the prescription-dispensing... | |
 | 1998 - 1120 lapas
...requirements are not necessary for the protection of the public health by reason of the drug's toxlclty or other potentiality for harmful effect, or the method...nec-essary to its use, and he finds that the drug 1 is safe and effective for use in self-medication as directed in proposed labeling 1 . A proposal... | |
 | 1998 - 1120 lapas
...necessary for the protection of the public health by reason of the §310.103 §310.201 drug's toxlcity or other potentiality for harmful effect, or the method...measures necessary to its use, and he finds that the dru? is safe and effective for use in self-medication as directed in proposed labeling. A proposal... | |
 | 1969 - 668 lapas
...reason of toe drug's toxicity or other potentiality for harmful effect, or toe method of its use, or toe collateral measures necessary to its use, and he finds that the drug is safe and effective for use in self -medication as directed in proposed labeling. A proposal to exempt a drug from toe prescription-dispensing... | |
| |
Commissioner finds such requirements are not necessary for the protection of the public health by reason of the drug's toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary to its use, and he... 
